Company / Net Income
ARS Pharmaceuticals, Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$171.3M
FY2025
5-year range
-$171.3M / $8.0M
FY2021-FY2025
Trend
-2241.8%
vs FY2024
Sector context
#144 of 216
Health Care
What the data says
Net Income changed -2242% YoY in FY2025, a notable deviation from the 5-year average annual change of -451%.
Based on SEC 10-K filings.
-$171M in FY2025.
Declined from -$54M to -$171M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#144 of 216 in Health CareTop 67% of 216This company -$171.3M Sector average $454.3M
▼
-137.7% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 2241.8% year-over-year.
- Ranks #144 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$171.3M | -2241.8% |
| FY2024 | $8.0M | +114.7% |
| FY2023 | -$54.4M | -168.6% |
| FY2022 | -$20.2M | +0.0% |
| FY2021 | -$20.2M | +38.6% |
| FY2020 | -$32.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026